DNA: One man’s trash is another man’s treasure, but there is no JUNK after all
June 24, 2013 by Demet Sag, Ph.D., CRA, GCP

John Rinn – Genomic Garbage Man (Photo credit: ChimpLearnGood)
DNA: One man’s trash is another man’s treasure, but there is no JUNK after all
Author: Demet Sag, PhD
One man’s trash is another man’s treasure, but there is no JUNK after all:
The JUNK has a meaning
Long non-coding RNAs recognized after transcriptome sequencing and studied more closely recently thanks to genomic tiling arrays, cDNA sequencing and RNA-Seq, which they have provided initial insights into the extent and depth of transcribed sequence across human and other genomes. How many are there in the genome? What are their mechanisms? How can we use them in molecular diagnostics and targeted therapies? How do they effect the function in a disease? Is it possible to modulate gene expression at the level of stem cell to redirect the cell differentiation? These are the main questions that we are looking for.
In early 90s actually first lincRNA was described, Xist. The main function was dosage compensation. Then in 2000s FANTOM consortium project changed the perspective on these long transcripts. Then they are called natural antisense transcripts (NATs), because very large number of these transcripts is overlapping with, and is transcribed in the antisense direction, to protein-coding genes. As a result of this study 11000 lincRNA discovered from full length cDNAs in mice. Later, yet another shift occur since these transcribed units are solely located in the introns or within “junk” DNA of protein-coding genes. Another independent study quantified that about 40% of protein-coding genes express NATs. Proven that there is nothing junk about DNA. Then, it was found that there are 8000 lincRNAs and among these 4000 are determined since they provide cell identity with multi-exogenic, polyadenylated, capped, ether in the cytoplasm or in the nucleus. However, even more recent studies show that there are about 20,000 lincRNAs. Furthermore, lincRNAs are classified under three distinct class: 1. Long-non-coding RNAs away from protein-coding genes, 2 NATs transcribed from the opposite strand of protein-coding genes, 3. Intronic lincRNAs expressed from within the introns of protein coding genes.

The human genome, categorized by function of each gene product, given both as number of genes and as percentage of all genes. (Photo credit: Wikipedia)
Their function is under study. However, keep in mind that they are redundant, so deleting or creating null mutations may or may not answer specific development questions. On the other hand, epigenetics, gene imprinting, and pathologies can be the best resource to identify their specific roles in biological functions and interactions. Distinct gene regulation either as a cis or trans element, gene imprinting, modulating alternative splicing, nuclear organization, determining a chromatin structure are under study. This will allow us to relate genome structure and function in health and disease better. Identification of their function during biological responses require a long way to be completed due to complexity since lincRNAs also regulate microRNAs. Regardless of many obstacles there is a progress. Disregulation of these lincRNA mainly observed in several cancer types, prostate, breast, hepatocellular carcinoma, colorectal, glioma and melanoma, possibly more. Most of the studies are done in vitro. However, there are many great model organism work as well, such as mice, zebra fish, and worm.
It was also not surprising that their regulation possibly under control of hormones based on circadian clock of our body. So better to sleep eight hour a day is not a cliché.
Next topic will include understanding of lincRNA mechanisms and epigenetics followed by lincRNAs during disease and cellular genesis.
Mechanism, Genome and Genetics:
”Long non-coding RNAs: insights into functions”. Mercer TR, Dinger ME, Mattick JS Nat. Rev. Genet. 2009;10:155–159. http://www.ncbi.nlm.nih.gov/pubmed/19188922
“Long Noncoding RNAs: Past, Present, and Future” Genetics 1 March 2013: 651-669. http://www.genetics.org/content/193/3/651.abstract
“RNA-protein analysis using a conditional CRISPR nuclease” Proc. Natl. Acad. Sci. USA 2 April 2013: 5416-5421. http://www.pnas.org/content/110/14/5416.abstract
“Noncoding RNA and Polycomb recruitment” RNA 1 April 2013: 429-442. http://rnajournal.cshlp.org/content/19/4/429.abstract
“Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs” Nucleic Acids Res 1 August 2012: 6391-6400. http://nar.oxfordjournals.org/content/40/14/6391.abstract
“Long noncoding RNAs regulate adipogenesis” Proc. Natl. Acad. Sci. USA 26 February 2013: 3387-3392. http://www.pnas.org/content/110/9/3387.abstract
“Circadian changes in long noncoding RNAs in the pineal gland” Proc. Natl. Acad. Sci. USA 14 August 2012: 13319-13324. http://www.pnas.org/content/109/33/13319.abstract
Animal and Development:
“Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis” Genome Res 1 March 2012: 577-591. http://genome.cshlp.org/content/22/3/577.abstract
“Genes for embryo development are packaged in blocks of multivalent chromatin in zebrafish sperm” Genome Res 1 April 2011: 578-589. http://genome.cshlp.org/content/21/4/578.abstract
“Long noncoding RNAs in C. elegans” Genome Res 1 December 2012: 2529-2540. http://genome.cshlp.org/content/22/12/2529.abstract
“A spatial and temporal map of C. elegans gene expression” Genome Res 1 February 2011: 325-341. http://genome.cshlp.org/content/21/2/325.abstract
“SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors” Genes Dev. 1 April 2013: 749-766. http://genesdev.cshlp.org/content/27/7/749.abstract
Other related articles published on this Open Access Online Scientific Journal include the following:

… therapies in a variety of animal models and contributed to regulatory CMC and IND-enabling safety and toxicology studies for inclusion in … sequences sort a-cardiac and b-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J. Cell. Biol., …

… and posttranscriptional mechanisms contributing to the regulatory network. We examined proinflammatory gene regulation in … articles What about Circular RNAs? (pharmaceuticalintelligence.com) How Genes Function …

… due to their broad scope and non-specificity in the human genome. “I am extremely pro-patent, but I simply believe that people … believe that individuals have an innate right to their own genome, or to allow their doctor to look at that genome, just like the lungs or …
Topics:
Health Economics and Outcomes Research,
Personalized Medicine & Genomic Research,
Medical and Population Genetics,
genome biology,
Biological Networks, Gene Regulation and Evolution,
Population Health Management, Genetics & Pharmaceut,
Genetics,
human genome,
DNA,
Regulated Clinical Trials: Design, Methods, Components ,
Biomarkers & Medical Diagnostics,
Supreme Court,
Genomic Testing: Methodology for Diagnosis,
Health Law & Patient Safety,
Nucleic acid sequence,
Patent,
weill cornell medical college,
Pharmacogenomics

… Intelligence
https://pharmaceuticalintelligence.com/2013/03/02/genome-sequenc…of-the-healthy/ Key Issues in
Genome Sequencing of Healthy Individuals Eric Topol, MD, Genomic Medicine I … touching on important controversies in the use of whole
genome …
Topics:
Chemical Genetics,
Cell Biology, Signaling & Cell Circuits,
Computational Biology/Systems and Bioinformatics,
genome biology,
Genetics,
Genome,
DNA,
Biology,
Full genome sequencing,
Health Law & Patient Safety,
Eric Topol,
eukaryotic,
Plant,
Healthy Individuals,
issues,
Benefits,
ethical issues

… of recombination is highly uneven across the human genome, as in all studied organisms. Substantial recombination active regions … this variation would require comparison of recombination genome-wide among many single genomes. Whole-genome amplification (WGA) of …
Topics:
Personalized Medicine & Genomic Research,
Chemical Genetics,
Medical and Population Genetics,
genome biology,
Biological Networks, Gene Regulation and Evolution,
Population Health Management, Genetics & Pharmaceut,
Molecular Genetics & Pharmaceutical,
Genomic Testing: Methodology for Diagnosis,
Genomic Endocrinology, Preimplantation Genetic Diagnosi,
Reproductive Biology & Bio Instrumentation,
Genome,
Sperm,
DNA,
chromosome,
amplification,
meiotic recombination,
aneuploidy,
Homologous chromosome,
Meiosis,
Multiple Displacement Amplification,
Genetic recombination

… Lev-Ari, PhD, RN and Pnina G. Abir-Am, PhD Putting Genome Interpretation to the Test 01/30/2013 Ashley Yeager How well do methods for interpreting genome variation work? Ashley Yeager takes a look at a community experiment that is trying to assess just how useful genome interpretation tools in real-world situations. At the American …
… genomes — through the end of this year, National Human Genome Research Institute estimates indicate. And in his book, The Creative … the interpretation of an apparently healthy person’s genome and that of an individual who is already affected by a disease, whether …
Topics:
Cardiovascular Pharmaceutical Genomics,
Personalized Medicine & Genomic Research,
Pharmaceutical R&D investment,
CANCER BIOLOGY & Innovations in Cancer Therapy,
Chemical Genetics,
Cell Biology, Signaling & Cell Circuits,
Computational Biology/Systems and Bioinformatics,
Medical and Population Genetics,
genome biology,
Biological Networks, Gene Regulation and Evolution,
Population Health Management, Genetics & Pharmaceut,
human genome,
National Institutes of Health,
Scripps Research Institute,
Proteomics,
Bio Instrumentation in Experimental Life Sciences Resea,
Massachusetts General Hospital,
DNA,
FDA Regulatory Affairs,
Clinical Trials and IRB related issues,
Biomarkers & Medical Diagnostics,
metabolomics,
Molecular Genetics & Pharmaceutical,
Genomic Testing: Methodology for Diagnosis,
Technology Transfer: Biotech and Pharmaceutical,
Health Law & Patient Safety,
Eric Topol,
national human genome research institute,
Encode,
NIST
… scary findings: the tale of John Lauerman’s whole genome sequencing FEBRUARY 15, 2012 Joe Thakuria draws John Lauerman’s blood for whole genome sequencing. By Madeleine Price Ball, licensed under … scary findings: the tale of John Lauerman’s whole genome sequencing » Joe Thakuria draws John …
Topics:
Personalized Medicine & Genomic Research,
Chemical Genetics,
Computational Biology/Systems and Bioinformatics,
Medical and Population Genetics,
genome biology,
Population Health Management, Genetics & Pharmaceut,
Genetics,
Harvard Medical School,
Bio Instrumentation in Experimental Life Sciences Resea,
Molecular Genetics & Pharmaceutical,
Genomic Testing: Methodology for Diagnosis,
Technology Transfer: Biotech and Pharmaceutical,
Full genome sequencing,
Harvard University,
Patient Experience: Personal Memories of Invasive Medic,
George Church,
John Lauerman,
Personal Genome Project
Topics:
Personalized Medicine & Genomic Research,
Pharmaceutical R&D investment,
Chemical Genetics,
Computational Biology/Systems and Bioinformatics,
Medical and Population Genetics,
genome biology,
Disease Biology, Small Molecules in Development of Ther,
Population Health Management, Genetics & Pharmaceut,
Cancer,
Foundation Medicine,
Proteomics,
DNA,
DNA Sequencing,
Biomarkers & Medical Diagnostics,
metabolomics,
AstraZeneca,
Molecular Genetics & Pharmaceutical,
Nature Medicine,
Stem Cells for Regenerative Medicine,
Genomic Testing: Methodology for Diagnosis,
Technology Transfer: Biotech and Pharmaceutical,
Full genome sequencing,
Genomic Endocrinology, Preimplantation Genetic Diagnosi,
Interviews with Scientific Leaders,
Pharmacogenomics,
Drug Delivery Platform Technology,
Digene,
Yuri Milner

Genome-Wide Detection of Single-Nucleotide and Copy-Number Variation of a Single … of DNA replication and the ability to amplify a whole genome. The amplicons are then sequenced either by whole-genome sequencing methods using Sanger-sequencing to verify any single …
Topics:
Health Economics and Outcomes Research,
Personalized Medicine & Genomic Research,
CANCER BIOLOGY & Innovations in Cancer Therapy,
Stem Cell,
Cell Biology, Signaling & Cell Circuits,
Computational Biology/Systems and Bioinformatics,
Medical and Population Genetics,
genome biology,
Biological Networks, Gene Regulation and Evolution,
Population Health Management, Genetics & Pharmaceut,
Cancer,
Genetics,
Genome,
Research,
health,
mutation,
ovarian cancer,
Bio Instrumentation in Experimental Life Sciences Resea,
Aviva Lev-Ari,
DNA,
DNA Sequencing,
Biology,
Cell Biology,
Genomic Testing: Methodology for Diagnosis,
Full genome sequencing,
genome sequence,
Personalized Medicine,
dna copy number,
Single Cell

… Aviva Lev-Ari, RN Genome Biol. 2012 Dec 13;13(12):R115. [Epub ahead of print] Whole-genome reconstruction and mutational signatures in gastric cancer. Nagarajan … read and DNA-PET sequencing to present the first whole-genome analysis of two gastric adenocarcinomas, one with chromosomal …
Topics:
Personalized Medicine & Genomic Research,
CANCER BIOLOGY & Innovations in Cancer Therapy,
Chemical Genetics,
Cell Biology, Signaling & Cell Circuits,
genome biology,
Chemical Biology and its relations to Metabolic Disease,
Population Health Management, Genetics & Pharmaceut,
Cancer,
Genetics,
Biology,
Molecular Genetics & Pharmaceutical,
Genomic Testing: Methodology for Diagnosis,
stomach cancer,
Stomach

… by interpreting the mathematical patterns in the cancer genome. Researchers at the University of Oslo, Norway (UiO) have developed a … Hospital and UiO. Finds the changed patterns in the genome There is much talk about finding the special cancer gene. In reality, …
0.000000
0.000000
Like this:
Like Loading...
Related
[…] One man’s trash is another man’s treasure, but there is no JUNK after all. […]
Dr. Sag,
Great article, great humor, too on a very serious matter.
Please browse the following link, if more are related, please added here.
https://pharmaceuticalintelligence.com/?s=JUNK
I am very happy to see you active.
6/30/2013 — last day for NEW articles going into Cancer e-Book.
your silent lamb will be in Chapter 4, 4.9 in the Genomics e-Book, let’s have this one in the Cancer e-Boo which has as strong a Genomics flavor as possible.
Thank you again.
You may wish to click on Genomics Volume 2 and Volume 3 — maybe we will work together on Volume three – 2014.
See
https://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-one-genomics-orientations-for-personalized-medicine/
4.7 4.7 The Underappreciated EpiGenome
4.9 “The SILENCE of the Lambs” Introducing The Power of Uncoded RNA
Demet Sag, PhD
4.10 DNA: One man’s trash is another man’s treasure, but there is no JUNK after all
Demet Sag, PhD
Hi Dr. Lev-Ari, I actually divide the subject on lincRNA into stem cells and development, epigenetics and diseases such as cancer (mainly), viral infection focus on HIV and heart.
Thank you again for your kind comment. As I am open for a new opportunity that can be in San Diego or San Francisco yet I will consider something from east coast as well.
Regards, Dee
If you have any questions or would like more information, please don’t hesitate to contact me via email demet.sag@gmail.com or phone at 919-259-1204.
I look forward to hearing from you soon.
Sincerely,
Dee Sag, PhD, CRA, GCP Translates science for personalized medicine with passion
http://www.vodinh.pratt.duke.edu/people.
References with picture.
I like the picture I am not sure that the BULK of the Topics should stay, nor the random section with the work genome three times.
Can we get the following: style and the picture??
We covered the Elevated Blood Pressure and High Adult Arterial Stiffness in the following articles on this Open Access Online Scientific Journal:
Pearlman, JD and A. Lev-Ari 5/24/2013 Imaging Biomarker for Arterial Stiffness: Pathways in Pharmacotherapy for Hypertension and Hypercholesterolemia Management
https://pharmaceuticalintelligence.com/2013/05/24/imaging-biomarker-for-arterial-stiffness-pathways-in-pharmacotherapy-for-hypertension-and-hypercholesterolemia-management/
Lev-Ari, A. 5/17/2013 Synthetic Biology: On Advanced Genome Interpretation for Gene Variants and Pathways: What is the Genetic Base of Atherosclerosis and Loss of Arterial Elasticity with Aging
https://pharmaceuticalintelligence.com/2013/05/17/synthetic-biology-on-advanced-genome-interpretation-for-gene-variants-and-pathways-what-is-the-genetic-base-of-atherosclerosis-and-loss-of-arterial-elasticity-with-aging/
Bernstein, HL and A. Lev-Ari 5/15/2013 Diagnosis of Cardiovascular Disease, Treatment and Prevention: Current & Predicted Cost of Care and the Promise of Individualized Medicine Using Clinical Decision Support Systems
https://pharmaceuticalintelligence.com/2013/05/15/diagnosis-of-cardiovascular-disease-treatment-and-prevention-current-predicted-cost-of-care-and-the-promise-of-individualized-medicine-using-clinical-decision-support-systems-2/
[…] DNA: One man’s trash is another man’s treasure, but there is no JUNK after all […]